Raynaud&rsquo;s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused by episodic vasospasm and ischemia of the extremities in response to cold or emotional stimuli. Usually, the condition is visible in distal digits; however, the discoloration can also be seen in the nose, ears and tongue.
With no cure at hand, Raynaud&rsquo;s phenomenon has symptomatic treatment options available in the market.
Gain more insights into the Raynaud&rsquo;s phenomenon, its causes, symptoms, epidemiological insights and available therapeutic options through DelveInsight&rsquo;s newsletter.
The newsletter offers all the recent activity in Raynaud&rsquo;s phenomenon market, its pipeline therapies, key companies, significant collaborations, licensing opportunities, and conferences that are taking place in the field.
Gain access to the newsletter for rich, precise and accurate Raynaud&rsquo;s phenomenon market insights by filling up a simple form towards the right.
Join DelveInsight&rsquo;s mailer list and get all the updates and recent happenings in the Life Science vertical delivered right in your inbox.

Raynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused by episodic vasospasm and ischemia of the extremities in response to cold or emotional stimuli. Usually, the condition is visible in distal digits; however, the discoloration can also be seen in the nose, ears and tongue. With no cure at hand, Raynaud’s phenomenon has symptomatic treatment options available in the market. Gain more insights into the Raynaud’s phenomenon, its causes, symptoms, epidemiological insights and available therapeutic options through DelveInsight’s newsletter. The newsletter offers all the recent activity in Raynaud’s phenomenon market, its pipeline therapies, key companies, significant collaborations, licensing opportunities, and conferences that are taking place in the field...

Raynaud's Phenomenon Newsletter

The Raynaud's Phenomenon newsletter offers all the recent activity in Raynaud’s phenomenon market, its pipeline therapies, key companies, significant collaborations, licensing opportunities, and conferences that are taking place in the field.